SEARCH

SEARCH BY CITATION

References

  • 1
    Cove Study Group. Controlled clinical evaluation of enalapril in dogs with heart failure: Results of the cooperative veterinary enalapril study group. J Vet Intern Med 1995;9:243252.
  • 2
    Pouchelon JL, Benazepril Veterinary Investigators Group. Treatment of heart failure in dogs with benazepril—Results of European double-blind placebo controlled study. Proc Am Coll Vet Intern Med Forum 1996;14: 745.
  • 3
    Hoyer J., Schulte KL, Lenz T. Clinical pharmacokinetics of an-giotensin converting enzyme (ACE) inhibitors in renal failure. Clin Pharmacokinet 1993;24:230254.
  • 4
    Burnier M., Biollaz J. Pharmacokinetic optimisation of angioten-sin converting enzyme (ACE) inhibitor therapy. Clin Pharmacokinet 1992;22:375384.
  • 5
    Tocco DJ, DeLuna FA, Duncan AEW, et al. The physiological disposition and metabolism of enalapril maleate in laboratory animals. Drug Metab Dispos 1982;10:1519.
  • 6
    Lulich JP, Osborne CA, O'Brien TD, Polzin DJ. Feline renal failure: Questions, answers, questions. Compend Cont Educ Pract Vet 1992;14:127154.
  • 7
    Riviere JE, Vaden SL. Drug therapy during renal disease and renal failure. In: OsborneCA, FincoDR, eds. Canine and Feline Ne-phrology and Urology, Baltimore , MD : Williams & Wilkins; 1995: 555572.
  • 8
    Waldmeier F., Schmid K. Disposition of [14C]-benazepril hydro-chloride in rat, dog and baboon. Drug Res 1989;39:6267.
  • 9
    Duffee NE, Bevill RF, Koritz GD, Schaeffer DJ. An experimental model for pharmacokinetic analysis in renal failure. J Pharmacokinet Biopharm 1990;18:7186.
  • 10
    King JN, Maurer M., Morrison CA, et al. Pharmacokinetics of the angiotensin-converting-enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, in dog. Xenobiotica 1997;27:819829.
  • 11
    Jayewardene AL, Seneviratne AK, Gambertoglio JG. Paired ion reversed-phase HPLC assay for the simultaneous determination of io-thalamic acid and para aminohippuric acid in plasma. J Liquid Chro-matogr 1994; 17:23952412.
  • 12
    Grizzle JE. The two-period change-over design and its use in clinical trials. Biometrics 1965;21:467480.
  • 13
    Finco DR, Brown SA, Crowell WA, Barsanti JA. Exogenous creatinine clearance as a measure of glomerular nitration rate in dogs with reduced renal mass. Am J Vet Res 1991;52:10291032.
  • 14
    Vaneerdeweg W., Buyssens N., De Winne T., et al. A standardized surgical technique to obtain a stable and reproducible chronic renal failure model in dogs. Eur Surg Res 1992;24:273282.
  • 15
    Fukuda S., Kopple JD. Chronic uremia syndrome in dogs induced with uranyl nitrate. Nephron 1980;25:139143.
  • 16
    King JN, Mauron C., Kaiser G. Pharmacokinetics of the active metabolite of benazepril, benazeprilat and inhibition of plasma angio-tensin-converting enzyme activity after single and repeated administrations to dogs. Am J Vet Res 1995;56:16201628.
  • 17
    MacDonald NJ, Sioufi A., Howie CA, et al. The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril. Br J Clin Pharmacol 1993;36:205209.
  • 18
    Hofmann S., Kersten U. Untersuchung zur Wirksamkeit und Verträglichkeit von Ramipril im Vergleich zu Captopril bei der Her-zinsuffizienz des Hundes. Dtsch Tierärztl Wschr 1996;103:159163.
  • 19
    Morisse B., Kersten U. Vergleichende Untersuchung mit den ACE-Hemmern Quinapril und Captopril zur Behandlung der dekom-pensierten Herzinsuffizienz des Hundes. Kleintierpraxis 1994;39:295308.
  • 20
    Schwab AJ, De Lannoy IAM, Goresky CA, et al. Enalaprilat handling by the kidney: Barrier-limited cell entry. Am J Physiol 1992; 263:F858F869.
  • 21
    Noormohamed FH, McNabb WR, Lant AE Pharmacokinetics and pharmacodynamic actions of enalapril in humans: Effect of pro-benecid treatment. J Pharmacol Exp Ther 1990;253:362368.
  • 22
    Shionoiri H. Pharmacokinetic drug interaction with ACE inhibitors. Clin Pharmacokinet 1993;25:2058.
  • 23
    Antilla M., Haataja M., Kasanen A. Pharmacokinetics of na-proxen in subjects with normal and impaired renal function. Eur J Clin Pharmacol 1980;18:263268.
  • 24
    Lefebvre HP, Laroute V., Alvinerie M., et al. The effect of experimental renal failure on tolfenamic acid disposition in the dog. Bio-pharm Drug Dispos 1997;18:7991.
  • 25
    Kang JY. The gastrointestinal tract in uremia. Dig Dis Sci 1993; 38:257268.